Data as of Oct 24
| +0.19 / +0.33%|
The 6 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 63.00, with a high estimate of 67.00 and a low estimate of 52.00. The median estimate represents a +9.26% increase from the last price of 57.66.
The current consensus among 7 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.